GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (NEOE:BMND) » Definitions » Cash Flow from Others

Biomind Labs (NEOE:BMND) Cash Flow from Others : C$0.04 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Cash Flow from Others?

Biomind Labs's cash flow from others for the three months ended in Sep. 2023 was C$-0.00 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.04 Mil.


Biomind Labs Cash Flow from Others Historical Data

The historical data trend for Biomind Labs's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Cash Flow from Others Chart

Biomind Labs Annual Data
Trend Dec21 Dec22
Cash Flow from Others
1.16 0.07

Biomind Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.03 - -

Biomind Labs Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.04 Mil.

Biomind Labs Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Biomind Labs's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomind Labs (NEOE:BMND) Business Description

Traded in Other Exchanges
Address
Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs (NEOE:BMND) Headlines

No Headlines